Use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA, in particular capable of blocking the biological activity of TrkA, for the preparation of a medicament for treating and/or preventing chronic pain.Linvention concerne lutilisation dun anticorps anti-TrkA capable dinhiber la liaison entre NGF et TrkA, capable notamment de bloquer lactivité biologique de TrkA, dans la préparation dun médicament permettant de traiter et/ou de prévenir des douleurs chroniques.
